Table 2.
Characteristics of speakers across different board review lectures
| All specialties | ASH (N = 38) | B & MDA (N = 70) | B & DF (N = 58) | GW (N = 65) | MSKCC (N = 62) | SCCA (N = 93) | P value | Overall (N=386) |
|---|---|---|---|---|---|---|---|---|
| Gender | ||||||||
| Women | 24.0 (63.2%) | 30.0 (42.9%) | 20.0 (34.5%) | 21.0 (32.3%) | 25.0 (40.3%) | 43.0 (46.2%) | 0.041 | 163 (42.2%) |
| Men | 14.0 (36.8%) | 40.0 (57.1%) | 38.0 (65.5%) | 44.0 (67.7%) | 37.0 (59.7%) | 50.0 (53.8%) | — | 223 (57.8%) |
| Specialty | ||||||||
| ABIM | 33.0 (86.8%) | 52.0 (74.3%) | 48.0 (82.8%) | 53.0 (81.5%) | 56.0 (90.3%) | 73.0 (78.5%) | — | 315 (81.6%) |
| Pathology | 1.00 (2.6%) | 3.00 (4.3%) | 3.00 (5.2%) | 2.00 (3.1%) | 0 (0%) | 0 (0%) | — | 9.00 (2.3%) |
| Pediatrics | 4.00 (10.5%) | 4.00 (5.7%) | 4.00 (6.9%) | 1.00 (1.5%) | 0 (0%) | 0 (0%) | — | 13.0 (3.4%) |
| Others | 0 (0%) | 11.0 (15.7%) | 3.00 (5.2%) | 9.00 (13.8%) | 6.00 (9.7%) | 20.0 (21.5%) | — | 49.0 (12.7%) |
| ABIM | ASH (N = 33) | B & MDA (N = 52) | B & DF (N = 48) | GW (N = 53) | MSKCC (N = 56) | SCCA (N = 73) | P value | Overall (N = 315) |
|---|---|---|---|---|---|---|---|---|
| Gender | ||||||||
| Women | 20.0 (60.6%) | 21.0 (40.4%) | 18.0 (37.5%) | 16.0 (30.2%) | 21.0 (37.5%) | 31.0 (42.5%) | 0.136 | 127 (40.3%) |
| Men | 13.0 (39.4%) | 31.0 (59.6%) | 30.0 (62.5%) | 37.0 (69.8%) | 35.0 (62.5%) | 42.0 (57.5%) | — | 188 (59.7%) |
| Certification | ||||||||
| Hematology | 6.00 (18.2%) | 3.00 (5.8%) | 6.00 (12.5%) | 13.0 (24.5%) | 5.00 (8.9%) | 7.00 (9.6%) | — | 40.0 (12.7%) |
| Oncology | 6.00 (18.2%) | 26.0 (50.0%) | 18.0 (37.5%) | 19.0 (35.8%) | 38.0 (67.9%) | 35.0 (47.9%) | — | 142 (45.1%) |
| Both | 20.0 (60.6%) | 22.0 (42.3%) | 20.0 (41.7%) | 18.0 (34.0%) | 13.0 (23.2%) | 23.0 (31.5%) | — | 116 (36.8%) |
| None | 1.00 (3.0%) | 1.00 (1.9%) | 4.00 (8.3%) | 3.00 (5.7%) | 0 (0%) | 8.00 (11.0%) | — | 17.0 (5.4%) |
| MOC∗ | ||||||||
| Yes | 20.0 (62.5%) | 25.0 (52.1%) | 26.0 (55.3%) | 26.0 (51.0%) | 24.0 (48.0%) | 44.0 (66.7%) | 0.334 | 165 (56.1%) |
| No | 12.0 (37.5%) | 23.0 (47.9%) | 21.0 (44.7%) | 25.0 (49.0%) | 26.0 (52.0%) | 22.0 (33.3%) | — | 129 (43.9%) |
| Location | ||||||||
| External | 33.0 (100%) | 23.0 (44.2%) | 0 (0%) | 49.0 (92.5%) | 0 (0%) | 10.0 (13.7%) | — | 115 (36.5%) |
| Local | 0 (0%) | 29.0 (55.8%) | 48.0 (100%) | 4.00 (7.5%) | 56.0 (100%) | 63.0 (86.3%) | — | 200 (63.5%) |
| Lectures given | ||||||||
| Mean (SD) | 1.30 (0.467) | 3.87 (2.40) | 2.94 (1.81) | 6.08 (4.96) | 3.05 (1.77) | 3.05 (2.15) | <0.001 | 3.50 (2.99) |
| Median [min, max] | 1.00 [1.00, 2.00] | 4.00 [1.00, 10.0] | 3.00 [1.00, 11.0] | 4.00 [1.00, 18.0] | 3.00 [1.00, 7.00] | 3.00 [1.00, 14.0] | — | 3.00 [1.00, 18.0] |
| Hematology experience (y) | ||||||||
| Mean (SD) | 13.9 (9.89) | 14.4 (9.31) | 19.7 (11.6) | 25.2 (13.3) | 16.9 (8.95) | 10.4 (8.93) | <0.001 | 16.9 (11.6) |
| Median [min, max] | 10.0 [4.00, 39.0] | 12.0 [2.00, 38.0] | 17.0 [2.00, 45.0] | 27.0 [2.00, 48.0] | 14.5 [4.00, 30.0] | 9.00 [2.00, 35.0] | — | 12.5 [2.00, 48.0] |
| Missing | 7.00 (21.2%) | 27.0 (51.9%) | 22.0 (45.8%) | 22.0 (41.5%) | 40.0 (71.4%) | 43.0 (58.9%) | — | 161 (51.1%) |
| Oncology experience (y) | ||||||||
| Mean (SD) | 16.6 (12.0) | 16.3 (9.00) | 18.8 (9.81) | 23.4 (10.7) | 16.2 (9.31) | 11.2 (8.63) | <0.001 | 16.6 (10.3) |
| Median [min, max] | 11.5 [4.00, 40.0] | 16.0 [0, 37.0] | 17.0 [2.00, 45.0] | 24.0 [8.00, 44.0] | 16.0 [3.00, 39.0] | 9.00 [2.00, 36.0] | — | 14.0 [0, 45.0] |
| Missing | 7.00 (21.2%) | 4.00 (7.7%) | 10.0 (20.8%) | 16.0 (30.2%) | 7.00 (12.5%) | 15.0 (20.5%) | — | 59.0 (18.7%) |
ABIM, American Board of Internal Medicine; SCCA, Seattle Cancer Care Alliance; ASH, American Society of Hematology; B & MDA, Baylor College of Medicine and M.D. Anderson Cancer Center; B & DF, The Brigham and Dana-Farber; GW, George Washington School of Medicine and Health Sciences; MOC, maintenance of certification; MSKCC, Memorial Sloan-Kettering Cancer Center; SD, standard deviation.
∗
21 entries are missing.